Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
AngioDynamics, Inc. (ANGO) had Cash Flow from Financial Activities of $-64.25M for the most recently reported fiscal year, ending 2024-05-31.
| Income Statement Financials | |
$303.91M |
|
$-184.35M |
|
$149.22M |
|
$154.70M |
|
$496.35M |
|
$-192.43M |
|
$0.80M |
|
$-191.64M |
|
$-191.64M |
|
$-184.35M |
|
$-184.35M |
|
$-184.35M |
|
$-184.35M |
|
$-192.43M |
|
$-5.25M |
|
40.18M |
|
40.18M |
|
$-4.59 |
|
$-4.59 |
|
| Balance Sheet Financials | |
$193.25M |
|
$35.67M |
|
$124.42M |
|
$317.67M |
|
$91.16M |
|
-- |
|
$20.93M |
|
$112.08M |
|
$205.59M |
|
$128.20M |
|
$205.59M |
|
40.43M |
|
| Cash Flow Statement Financials | |
$-28.16M |
|
$123.72M |
|
|
Cash Flow from Financial Activities |
$-64.25M |
$44.62M |
|
$76.06M |
|
$31.44M |
|
$10.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
50.90% |
|
-63.32% |
|
-63.32% |
|
-1.73% |
|
-63.06% |
|
-60.66% |
|
$103.82M |
|
-- |
|
-- |
|
-- |
|
0.96 |
|
2.46 |
|
6.97 |
|
52.38 |
|
-89.67% |
|
-143.79% |
|
-58.03% |
|
-89.67% |
|
$5.08 |
|
$2.58 |
|
$-0.70 |
|